ArticleBMC cardiovascular disorders2026
Right ventricular-pulmonary arterial uncoupling: an underrecognized predictor of in-hospital outcomes in acute myocardial infarction.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRight ventricular (RV) function is an underrecognized determinant of outcomes in acute myocardial infarction (AMI) and is not routinely incorporated into risk stratification. Beyond primary RV involvement, interventricular interdependence and ventriculoarterial coupling suggest a more substantial role of the RV in acute hemodynamic adaptation than previously appreciated. The TAPSE/sPAP ratio, a non-invasive index of RV-pulmonary arterial (RV-PA) coupling reflecting the interaction between RV function and afterload, may capture this interaction, but its prognostic role in AMI remains insufficiently defined.
methodsWe retrospectively analyzed 290 consecutive AMI patients (138 STEMI, 152 NSTEMI). The primary endpoint was in-hospital major adverse events (MAE), defined as a composite of all-cause mortality, recurrent myocardial infarction, acute decompensated heart failure, acute kidney injury, stroke, or major bleeding. Multivariable logistic regression was performed to evaluate the prognostic value of TAPSE/sPAP. A sensitivity analysis was conducted using major adverse cardiovascular events (MACE), defined as the composite of in-hospital events excluding major bleeding.
resultsMAE occurred in 53 patients (18.3%). In multivariable analysis, TAPSE/sPAP was an independent predictor of MAE (OR 0.16, 95% CI 0.03-0.73, p = 0.017). Chronic kidney disease and Shock Index also remained significant predictors, whereas LVEF was not independently associated. Sensitivity analysis using MACE confirmed the prognostic value of TAPSE/sPAP (OR 0.12, 95% CI 0.02-0.62, p = 0.011). ROC analysis identified a TAPSE/sPAP threshold of 0.47 mm/mmHg, with 83.3% sensitivity and 85.6% specificity for predicting MAE.
conclusionsThe TAPSE/sPAP ratio is a non-invasive independent predictor of in-hospital complications in AMI and remains associated with adverse outcomes after adjustment for clinical risk factors. Early assessment of RV-pulmonary arterial coupling may improve identification of high-risk patients and guide targeted clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.